Question 1

Am I eligible to participate in this trial based on my current health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy clinical trial (NCT00053638). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of the new tablet compared to other treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy clinical trial (NCT00053638). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to visit the clinic during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy clinical trial (NCT00053638). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy clinical trial (NCT00053638). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy clinical trial (NCT00053638). Contact the study team or your healthcare provider for specific answers.

What this study is about